$0.74
+0.04 (+6.06%)
Open$0.70
Previous Close$0.70
Day High$0.75
Day Low$0.70
52W High$1.58
52W Low$0.48
Volume—
Avg Volume324.2K
Market Cap24.20M
P/E Ratio—
EPS$-1.17
SectorBiotechnology
Analyst Ratings
Strong Buy
9 analysts
Price Target
+3,642.4% upside
Current
$0.74
$0.74
Target
$27.69
$27.69
$21.92
$27.69 avg
$40.08
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 2.17M | 2.18M | 3.54M |
| Net Income | -41,083,241 | -37,209,335 | -86,327 |
| Profit Margin | -1,893.6% | -1,798.9% | -2.4% |
| EBITDA | -39,919,158 | -38,163,630 | -134,724 |
| Free Cash Flow | — | — | -61,141 |
| Rev Growth | -0.6% | -0.6% | +8.8% |
| Debt/Equity | — | — | 0.64 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $249.46 | -0.54% | 118.6 | 430.95B |
| AMGN | Amgen Inc | $415.21 | -0.63% | 25.1 | 219.39B |
| GILD | Gilead Sciences Inc | $138.36 | +0.16% | — | 165.85B |
| VRTX | Vertex Pharmaceuticals Inc | $505.75 | -2.07% | 28.3 | 124.51B |
| REGN | Regeneron Pharmaceuticals | $803.48 | -0.31% | 18.4 | 79.53B |
| ALNY | Alnylam Pharmaceuticals Inc | $228.65 | +0.67% | 35.2 | 28.41B |